DPPPRED-IV: An Ensembled QSAR-Based Web Server for the Prediction of Dipeptidyl Peptidase 4 Inhibitors
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125579 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Laureano E Carpio und 5 weiteren Autor:innen. Beteiligte Einrichtung: MolDrug AI Systems SL, Parque Tecnológico de Valencia, 46980 Valencia, Spain. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Quantitative Structure-Activity Relationship, Dipeptidyl Peptidase 4, Software. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Generalitat Valenciana, Agencia Valenciana de la innovació.
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is a complex and prevalent metabolic disorder, and dipeptidyl peptidase 4 (DPP4) inhibitors have proven effective, yet the identification of novel inhibitors remains challenging due to the vastness of chemical space. In this study, we developed DPPPRED-IV, a web-based ensembled system integrating both binary classification and continuous regression Quantitative Structure Activity Relationships (QSAR) models to predict human DPP4 inhibitory activity. A curated dataset of 4 676 ChEMBL compounds was subjected to genetic algorithm descriptor selection and multiple machine learning algorithms; classification models were combined via a soft voting ensemble, while regression models estimated IC50 values. All models underwent external 10-fold cross-validation and applicability domain analysis. The final models were integrated into a user-friendly web server, allowing predictions from SMILES inputs. Experimental testing of 29 MolPort compounds at 1.5 µM confirmed that 14 predicted actives exhibited significant inhibition, supporting the tool’s performance in early-stage screening. DPPPRED IV is freely available within the ChemoPredictionSuite and offers a resource to accelerate decision making, reduce costs and minimize animal use in T2DM drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MolDrug AI Systems SL, Parque Tecnológico de Valencia, 46980 Valencia, Spain.
- ProtoQSAR SL, Parque Tecnológico de Valencia, 46980 Valencia, Spain.
- Microbiome Innovation in Nutrition & Health Research Unit, Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), 46980 Valencia, Spain.
ORCID-Profile: Marta Olivares, Rita Ortega-Vallbona, Eva Serrano-Candelas, Yolanda Sanz
Förderung
- Generalitat Valenciana
- Agencia Valenciana de la innovació
Zitieren
APA
Carpio, L. E., Olivares, M., Ortega-Vallbona, R., Serrano-Candelas, E., Sanz, Y., & Gozalbes, R. (2025). DPPPRED-IV: An Ensembled QSAR-Based Web Server for the Prediction of Dipeptidyl Peptidase 4 Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125579
Vancouver
Carpio LE, Olivares M, Ortega-Vallbona R, Serrano-Candelas E, Sanz Y, Gozalbes R. DPPPRED-IV: An Ensembled QSAR-Based Web Server for the Prediction of Dipeptidyl Peptidase 4 Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125579
BibTeX
@article{Carpio2025,
author = {Carpio, Laureano E and Olivares, Marta and Ortega-Vallbona, Rita and Serrano-Candelas, Eva and Sanz, Yolanda and Gozalbes, Rafael},
title = {DPPPRED-IV: An Ensembled QSAR-Based Web Server for the Prediction of Dipeptidyl Peptidase 4 Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125579}
}
EUVIMED